408 related articles for article (PubMed ID: 21824415)
21. Cell cloning-based transcriptome analysis in Rett patients: relevance to the pathogenesis of Rett syndrome of new human MeCP2 target genes.
Nectoux J; Fichou Y; Rosas-Vargas H; Cagnard N; Bahi-Buisson N; Nusbaum P; Letourneur F; Chelly J; Bienvenu T
J Cell Mol Med; 2010 Jul; 14(7):1962-74. PubMed ID: 20569274
[TBL] [Abstract][Full Text] [Related]
22. Graded and pan-neural disease phenotypes of Rett Syndrome linked with dosage of functional MeCP2.
Chen X; Han X; Blanchi B; Guan W; Ge W; Yu YC; Sun YE
Protein Cell; 2021 Aug; 12(8):639-652. PubMed ID: 32851591
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide analysis reveals methyl-CpG-binding protein 2-dependent regulation of microRNAs in a mouse model of Rett syndrome.
Wu H; Tao J; Chen PJ; Shahab A; Ge W; Hart RP; Ruan X; Ruan Y; Sun YE
Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18161-6. PubMed ID: 20921386
[TBL] [Abstract][Full Text] [Related]
24. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
[TBL] [Abstract][Full Text] [Related]
25. Differential brain region-specific expression of MeCP2 and BDNF in Rett Syndrome patients: a distinct grey-white matter variation.
Pejhan S; Siu VM; Ang LC; Del Bigio MR; Rastegar M
Neuropathol Appl Neurobiol; 2020 Dec; 46(7):735-750. PubMed ID: 32246495
[TBL] [Abstract][Full Text] [Related]
26. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets.
Jordan C; Li HH; Kwan HC; Francke U
BMC Med Genet; 2007 Jun; 8():36. PubMed ID: 17584923
[TBL] [Abstract][Full Text] [Related]
27. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.
Gabel HW; Kinde B; Stroud H; Gilbert CS; Harmin DA; Kastan NR; Hemberg M; Ebert DH; Greenberg ME
Nature; 2015 Jun; 522(7554):89-93. PubMed ID: 25762136
[TBL] [Abstract][Full Text] [Related]
28. Reduced expression of MECP2 affects cell commitment and maintenance in neurons by triggering senescence: new perspective for Rett syndrome.
Squillaro T; Alessio N; Cipollaro M; Melone MA; Hayek G; Renieri A; Giordano A; Galderisi U
Mol Biol Cell; 2012 Apr; 23(8):1435-45. PubMed ID: 22357617
[TBL] [Abstract][Full Text] [Related]
29. The impact of MECP2 mutations in the expression patterns of Rett syndrome patients.
Ballestar E; Ropero S; Alaminos M; Armstrong J; Setien F; Agrelo R; Fraga MF; Herranz M; Avila S; Pineda M; Monros E; Esteller M
Hum Genet; 2005 Jan; 116(1-2):91-104. PubMed ID: 15549394
[TBL] [Abstract][Full Text] [Related]
30. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
[TBL] [Abstract][Full Text] [Related]
31. MeCP2 dysfunction in Rett syndrome and related disorders.
Moretti P; Zoghbi HY
Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
[TBL] [Abstract][Full Text] [Related]
32. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome.
Horike S; Cai S; Miyano M; Cheng JF; Kohwi-Shigematsu T
Nat Genet; 2005 Jan; 37(1):31-40. PubMed ID: 15608638
[TBL] [Abstract][Full Text] [Related]
33. Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain.
Gibson JH; Slobedman B; K N H; Williamson SL; Minchenko D; El-Osta A; Stern JL; Christodoulou J
BMC Neurosci; 2010 Apr; 11():53. PubMed ID: 20420693
[TBL] [Abstract][Full Text] [Related]
34. The biological functions of the methyl-CpG-binding protein MeCP2 and its implication in Rett syndrome.
Nan X; Bird A
Brain Dev; 2001 Dec; 23 Suppl 1():S32-7. PubMed ID: 11738839
[TBL] [Abstract][Full Text] [Related]
35. Deciphering Rett syndrome with mouse genetics, epigenomics, and human neurons.
Tao J; Wu H; Sun YE
Int Rev Neurobiol; 2009; 89():147-60. PubMed ID: 19900619
[TBL] [Abstract][Full Text] [Related]
36. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology.
Ballas N; Lioy DT; Grunseich C; Mandel G
Nat Neurosci; 2009 Mar; 12(3):311-7. PubMed ID: 19234456
[TBL] [Abstract][Full Text] [Related]
37. Ocular MECP2 protein expression in patients with and without Rett syndrome.
Jain D; Singh K; Chirumamilla S; Bibat GM; Blue ME; Naidu SR; Eberhart CG
Pediatr Neurol; 2010 Jul; 43(1):35-40. PubMed ID: 20682201
[TBL] [Abstract][Full Text] [Related]
38. Defects in brainstem neurons associated with breathing and motor function in the Mecp2R168X/Y mouse model of Rett syndrome.
Johnson CM; Zhong W; Cui N; Wu Y; Xing H; Zhang S; Jiang C
Am J Physiol Cell Physiol; 2016 Dec; 311(6):C895-C909. PubMed ID: 27653984
[TBL] [Abstract][Full Text] [Related]
39. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome.
Urdinguio RG; Fernandez AF; Lopez-Nieva P; Rossi S; Huertas D; Kulis M; Liu CG; Croce CM; Calin GA; Esteller M
Epigenetics; 2010 Oct; 5(7):656-63. PubMed ID: 20716963
[TBL] [Abstract][Full Text] [Related]
40. The neurobiology of Rett syndrome.
Akbarian S
Neuroscientist; 2003 Feb; 9(1):57-63. PubMed ID: 12580340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
